290 results on '"Bortoli, N."'
Search Results
2. T.08.5: CLINICAL AND ANORECTAL PHYSIOLOGY OUTCOMES OF BIOFEEDBACK FOR REFRACTORY CONSTIPATION DUE TO OUTLET DYSFUNCTION
3. BOC.03.8: TWO PUSHES MAY BE ENOUGH TO DIAGNOSE DEFECATION DISORDERS: A MODIFIED LONDON PROTOCOL TO PERFORM HIGH-DEFINITION ANORECTAL MANOMETRY
4. OC.07.10: SARCOPENIA IS A RISK FACTOR OF POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE
5. OC.08.8: MANOMETRIC SCREENING OF PATIENTS WITH LARYNGOPHARYNGEAL REFLUX DISEASE WITH THE NOVEL MILAN SCORE
6. OC.14.3: CLINICAL PREDICTORS OF BIOFEEDBACK OUTCOME FOR REFRACTORY CONSTIPATION DUE TO OUTLET DYSFUNCTION
7. OC.15.6: SERUM EOTAXIN-3 AND IL-10 ARE USEFUL NON-INVASIVE BIOMARKERS FOR THE DIAGNOSIS AND IDENTIFICATION OF HISTOLOGICAL REMISSION OF EOSINOPHILIC ESOPHAGITIS: A PROSPECTIVE STUDY
8. OC.14.1: BIOFEEDBACK IS EFFECTIVE TREATMENT FOR REFRACTORY CONSTIPATION DUE TO FUNCTIONAL DEFECATION DISORDERS, NOT FOR ISOLATED STRUCTURAL PELVIC FLOOR DYSFUNCTION
9. T.01.7: PREDICTORS OF EOSINIPHILIC ESOPHAGITIS IN PATIENTS WITH DYSPHAGIA AND NORMAL ENDOSCOPY
10. T.01.10: IMPACT OF ESOPHAGEAL HYPERVIGILANCE AND ADAPTIVE BEHAVIORS ON THE DISSOCIATION BETWEEN SYMPTOMS AND HISTOLOGICAL ACTIVITY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: A PROSPECTIVE STUDY
11. T.01.6: BILE ACID REFLUX IS ASSOCIATED WITH INCREASED PREVALENCE OF DYSPLASIA AND LONGER LENGTH IN BARRETT'S ESOPHAGUS
12. OC.17.10: SINGLE-SESSION HALO360 RADIOFREQUENCY ABLATION IS SUFFICIENT TO ERADICATE DYSPLASIA IN MOST PATIENTS WITH BARRETT'S ESOPHAGUS: A SINGLE-CENTER EXPERIENCE
13. T.09.3: HIGH RESOLUTION MANOMETRY ASSESSMENT IN EROSIVE REFLUX DISEASE
14. T.01.3: EXTERNALVALIDATION OF MANOMETRIC SCORE OF GERD PROBABILITY IN A HIGH-VOLUME TERTIARY REFERRAL CENTER
15. OC.08.6: EXTERNALVALIDATION DEMONSTRATES HIGH PREDICTIVE VALUE OF THE LYON SCORE: A NOVEL REFLUX SCORING SYSTEM BASED ON THE LYON CONSENSUS 2.0
16. OC.06.2 ULTRASOUND EVALUATION OF PELVIC FLOOR DYNAMIC IN CONSTIPATED PATIENTS: A NEW APPROACH TO DIAGNOSE FUNCTIONAL DEFECATION DISORDERS
17. OC.11.1 DIAGNOSTIC ACCURACY OF LONDON PROTOCOL RECORDING PERIOD CHANGES APPLIED TO HIGH-DEFINITION ANORECTAL MANOMETRY
18. T.01.9 WHICH CHRONOPTYPE IS MORE FREQUENT IN PATIENTS WITH OBJECTIVE GERD AND HOW DOES IT AFFECT THE RESPONSE TO PPI THERAPY?
19. T.05.3 BASELINE ANXIETY SCORES PREDICT ESCALATION TO HIGHER DOSES OF PAROXETINE IN PATIENTS WITH FUNCTIONAL HEARTBURN AND REFLUX HYPERSENSITIVITY
20. T.05.2 DO WE NEED THREE DIFFERENT TYPES OF ESOPHAGOGASTRIC JUNCTION?
21. PC.01.4 THE ROLE OF LARYNGOSCOPY IN GERD PATIENTS WITH ATYPICAL SYMPTOMS - A MULTICENTRE STUDY
22. T.01.6 THE EFFICACY OF SIX-FOOD ELIMINATION DIET IS LOWER DURING POLLEN SEASON IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS SENSITIZED TO POLLENS
23. OC.16.2 STRAIGHT LEG RAISE TEST TO ASSESS ESOPHAGEAL CONTRACTION RESERVE IN NORMAL COMPARED TO INEFFECTIVE ESOPHAGEAL MOTILITY
24. T.05.1 IMPEDANCE-PH FINDINGS CONFIRM THAT GRADE B ESOPHAGITIS PROVIDES CONCLUSIVE DIAGNOSIS OF GASTROESOPHAGEAL REFLUX DISEASE
25. T.02.6 EFFECTIVENESS OF VERY LOW-VOLUME PREPARATION FOR COLONOSCOPY IN HOSPITALIZED OLDER PATIENTS: SINGLE CENTER OBSERVATIONAL TRIAL
26. OC.16.2 STRAIGHT LEG RAISE TEST TO ASSESS ESOPHAGEAL CONTRACTION RESERVE IN NORMAL COMPARED TO INEFFECTIVE ESOPHAGEAL MOTILITY
27. OC.11.1 DIAGNOSTIC ACCURACY OF LONDON PROTOCOL RECORDING PERIOD CHANGES APPLIED TO HIGH-DEFINITION ANORECTAL MANOMETRY
28. T.01.1 APPLICATION OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS: EVALUATION OF PATIENTS WITH INCONCLUSIVE DIAGNOSIS AND NEW IMPEDANCE-PH PARAMETERS
29. T.01.6 STRAIGHT LEG RAISE TEST: A NOVEL PROVOCATIVE TEST TO ASSESS ESOPHAGEAL CONTRACTION RESERVE AT HIGH-RESOLUTION MANOMETRY
30. OC.05.4 SYSTEMATIC REVIEW WITH META-ANALYSIS: ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF ESOPHAGEAL DISEASES
31. OC.03.3 EOSINOPHILIC ESOPHAGITIS: MOST NON-RESPONDERS TO FIRST COURSE OF PPIS ACHIEVE SUSTAINED HISTOLOGICAL REMISSION FOLLOWING SEQUENTIAL TREATMENT WITH TOPICAL STEROIDS AND SECOND COURSE OF PPIS MONOTHERAPY
32. T.07.6 PATIENTS REFERRED TO ANORECTAL MANOMETRY BEFORE AND DURING THE COVID PANDEMIC: ARE THEY DIFFERENT?
33. OC.02.6 BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN’S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY
34. OC.11.5 IMPACT OF REFLUX BURDEN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY ACCORDING TO THE CRITERIA PROPOSED BY CCV4.0 COMPARED TO CCV3.0
35. T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
36. AF.30 RAISING CHILDREN ON A VEGAN DIET: PARENTS’ DECISIONS AND RELATIONSHIP WITH PEDIATRICIANS AND SOCIETY
37. OC.01.5 RAPID DRINK CHALLENGE DURING HIGH RESOLUTION MANOMETRY IS USEFUL TO PREDICT ESOPHAGEAL EMPTYING IN ACHALASIA PATIENTS AFTER TREATMENT
38. AF.16 DIAGNOSTIC DELAY AND MISDIAGNOSIS IN EOSINOPHILIC ESOPHAGITIS
39. AF.44 IG GLYCOSYLATION IN ULCERATIVE COLITIS: IT IS TIME FOR NEW BIOMARKERS
40. AF.15 EOSINOPHILIC ESOPHAGITIS IS FREQUENTLY ASSOCIATED WITH DISORDERS OF PERISTALSIS AT HIGH-RESOLUTION MANOMETRY: A PROSPECTIVE SINGLE-CENTRE CASE-CONTROL STUDY
41. OC.01.10 EGJ OUTFLOW OBSTRUCTION ACCORDING TO THE NEW CHICAGO CLASSIFICATION: HOW MANY DIAGNOSES MIGHT BE CONFIRMED?
42. OC.03.4 ESOPHAGO-GASTRIC JUNCTION CONTRACTILE INTEGRAL (EGJ-CI) MAY PREDICT RESPONSE TO TREATMENT IN PATIENTS WITH ESOPHAGEAL ACHALASIA
43. T01.02.10 PROVOCATIVE TESTS DURING HIGH-RESOLUTION MANOMETRY MAY BE HELPFUL TO DISTINGUISH PATIENTS WITH EOSINOPHILIC ESOPHAGITIS RESPONDING TO PPI THERAPY
44. T01.02.11 WHICH CORRELATION BETWEEN OCULAR SURFACE DISEASE AND GERD? A PILOT STUDY
45. T05.02.4 BILE ACID MALABSORPTION: AN OVERLOOKED DIAGNOSIS?
46. T01.02.17 CLINICAL USEFULNESS OF SECOND-GENERATION BARRIER DRUGS IN GERD PATIENTS WITH ATYPICAL SYMPTOMS: A-6-MONTHS PROSPECTIVE STUDY
47. T01.02.23 ROLE OF ENVIRONMENTAL FACTORS ON THE OUTCOME OF GASTROESOPHAGEAL REFLUX DISEASE: 6 MONTHS PROSPECTIVE STUDY
48. OC.03.2 MULTIPLE RAPID SWALLOW DISCRIMINATES FUNCTIONAL FROM ANATOMICAL ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION
49. T01.02.19 IS IT POSSIBILE TO WITHDRAW PPIS THERAPY IN GERD PATIENTS? A PROSPECTIVE STUDY ON 216 PATIENTS USING A SECOND GENARTION BARRIER DRUG
50. T01.01.22 HIGH RESOLUTION MANOMETRY TRADITIONAL PARAMETERS ARE NOT USEFUL TO PREDICT RESPONSE TO ENDOSCOPIC TREATMENT IN PATIENTS WITH ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.